Tania Hernández-Jiménez

Toxicity Assessment of [177Lu]Lu−iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes

Tania Hernández-Jiménez, Pedro Cruz-Nova, Alejandra Ancira-Cortez et al. · Nanomaterials · 2022 · 18 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image

Myrna Luna‐Gutiérrez, Blanca Ocampo‐García, Nallely Jiménez‐Mancilla et al. · Pharmaceutics · 2022 · 17 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: synthesis and assessment of the ability to target the prostate specific membrane antigen

Tania Hernández-Jiménez, Guillermina Ferro‐Flores, Blanca Ocampo‐García et al. · Journal of Radioanalytical and Nuclear Chemistry · 2018 · 15 citations

Medicine, Medicinal Chemistry, Molecular Pharmaceutics +12

225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins

Tania Hernández-Jiménez, Guillermina Ferro‐Flores, Enrique Morales-Ávila et al. · Molecules · 2022 · 14 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Freeze-dried multi-dose kits for the fast preparation of 177Lu-Tyr3-octreotide and 177Lu-PSMA(inhibitor) under GMP conditions

Myrna Luna‐Gutiérrez, Tania Hernández-Jiménez, Luis Serrano-Espinoza et al. · Journal of Radioanalytical and Nuclear Chemistry · 2017 · 10 citations

Pharmacy, Pharmaceutics, Pharmacology +7